Assessment the effect of ovarian stimulation with and without letrozole in IVF/ICSI outcomes.

The effect of ovarian stimulation with and without letrozole in improves in vitro fertilization outcome in low responder patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201701291952N8

Enrollment

160

Registered

2017-09-19

Start date

2017-02-03

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility

Interventions

Intervention 1: In intervention group,gonadotropins (150 units FSH and hmg) and 5 mg letrozole will prescribed in the first 5 days of ovarian stimulation cycle. Intervention 2: In control group,p,go

Treatment - Drugs

In intervention group,gonadotropins (150 units FSH and hmg) and 5 mg letrozole will prescribed in the first 5 days of ovarian stimulation cycle.

In control group,p,gonadotropins (150 units FSH and hmg) will prescribed in the first 5 days of ovarian stimulation cycle.

Eligibility

Sex/Gender

Female

Age

15 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria :infertile women with less than 3 oocyte; AMH <1, AFC<5 oocyte in each ovarian Exclusion criteria:Other causes of infertility

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Clinical pregnancy. Timepoint: 3 weeks after emberyo transfer. Method of measurement: Ultrasonography.	—

Secondary

Measure	Time frame
Implantation. Timepoint: 14 days after embryo transfer. Method of measurement: serum level of BHCG.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZohre Lavasani

Tehran University of Medical Science

zohrehlavasani@yahoo.com+98 21 7771 9922

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026